InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,589.04
(
-0.80%
)
US TECH 100
19,764.56
(
-1.76%
)
Dow Jones
39,826.84
(
0.27%
)
Brent Oil
85.10
(
0.05%
)
Bitcoin
57,484.00
(
-0.47%
)
Post# of 92948
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

lasers

Send PM Follow Ignore
Followers 594
Posts 20577
Boards Moderated 0
Alias Born 02/01/2012

lasers

Re: rumper post# 80937

Friday, 02/06/2015 9:24:35 AM

Friday, February 06, 2015 9:24:35 AM

Post# of 92948
rumper Rather then get into a full discussion regarding cloning, probably better IMO to stay with $OCAT's autologous IPSC from the patient's own tissues. In that way there is no controversy while the DNA is 100% the patient's and fully acceptable no rejection to be concerned with.

Yes VCEL is 100% autologous technology from bone marrow with the same bad management difficult beginnings as $OCAT but now starting to run under new CEO lawyer Nick Colangelo. Paul Wotton and Nick Colangelo share many features of the same management style IMO and therefore a good fit for Wotton on VCEL's BOD.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up